Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does MOCLOBEMIDE Cause Disturbance in attention? 26 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 26 reports of Disturbance in attention have been filed in association with MOCLOBEMIDE. This represents 5.6% of all adverse event reports for MOCLOBEMIDE.

26
Reports of Disturbance in attention with MOCLOBEMIDE
5.6%
of all MOCLOBEMIDE reports
0
Deaths
13
Hospitalizations

How Dangerous Is Disturbance in attention From MOCLOBEMIDE?

Of the 26 reports, 13 (50.0%) required hospitalization.

Is Disturbance in attention Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for MOCLOBEMIDE. However, 26 reports have been filed with the FAERS database.

What Other Side Effects Does MOCLOBEMIDE Cause?

Serotonin syndrome (255) Intentional overdose (216) Suicide attempt (194) Acute kidney injury (193) Metabolic acidosis (182) Physical deconditioning (178) Major depression (176) Drug interaction (135) Toxicity to various agents (62) Drug ineffective (50)

What Other Drugs Cause Disturbance in attention?

LEVOTHYROXINE (1,718) METHYLPHENIDATE (1,414) AMPHETAMINE ASPARTATE\AMPHETAMINE\DEXTROAMPHETAMINE SACCHARATE\DEXTROAMPHETAMINE (1,321) DULOXETINE (986) PREGABALIN (950) LISDEXAMFETAMINE DIMESYLATE (911) OXYCODONE (829) QUETIAPINE (747) ACETAMINOPHEN\HYDROCODONE (746) ACETAMINOPHEN\OXYCODONE (734)

Which MOCLOBEMIDE Alternatives Have Lower Disturbance in attention Risk?

MOCLOBEMIDE vs MODAFINIL MOCLOBEMIDE vs MOGAMULIZUMAB MOCLOBEMIDE vs MOGAMULIZUMAB-KPKC MOCLOBEMIDE vs MOLNUPIRAVIR MOCLOBEMIDE vs MOLSIDOMINE

Related Pages

MOCLOBEMIDE Full Profile All Disturbance in attention Reports All Drugs Causing Disturbance in attention MOCLOBEMIDE Demographics